117 related articles for article (PubMed ID: 11216953)
61. A comparative evaluation of therapeutic effects of once a day dose of losartan potassium versus enalapril maleate in mild to moderate essential hypertension.
Neki NS; Arora P
J Indian Med Assoc; 2001 Nov; 99(11):640-1. PubMed ID: 12022207
[TBL] [Abstract][Full Text] [Related]
62. Alveolar--capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure.
Guazzi M; Pontone G; Brambilla R; Agostoni P; Rèina G
Eur Heart J; 2002 Mar; 23(6):467-76. PubMed ID: 11863349
[TBL] [Abstract][Full Text] [Related]
63. Losartan and enalapril are comparable in reducing proteinuria in children.
Webb NJ; Shahinfar S; Wells TG; Massaad R; Gleim GW; Santoro EP; Sisk CM; Lam C
Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
[TBL] [Abstract][Full Text] [Related]
64. Can a membrane oxygenator be a model for lung NO and CO transfer?
Borland C; Dunningham H; Bottrill F; Vuylsteke A
J Appl Physiol (1985); 2006 May; 100(5):1527-38. PubMed ID: 16397061
[TBL] [Abstract][Full Text] [Related]
65. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan.
Nawarskas JJ; Townsend RR; Cirigliano MD; Spinler SA
Am J Hypertens; 1999 Aug; 12(8 Pt 1):784-9. PubMed ID: 10480471
[TBL] [Abstract][Full Text] [Related]
66. Effects of body position on the carbon monoxide diffusing capacity in patients with chronic heart failure: relation to hemodynamic changes.
Faggiano P; D'Aloia A; Simoni P; Gualeni A; Foglio K; Ambrosino N; Giordano A
Cardiology; 1998; 89(1):1-7. PubMed ID: 9452149
[TBL] [Abstract][Full Text] [Related]
67. Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
He YM; Feng L; Huo DM; Yang ZH; Liao YH
Nephrology (Carlton); 2013 Sep; 18(9):605-14. PubMed ID: 23869492
[TBL] [Abstract][Full Text] [Related]
68. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure.
Agostoni PG; Guazzi M; Bussotti M; Grazi M; Palermo P; Marenzi G
J Am Coll Cardiol; 2000 Nov; 36(5):1600-4. PubMed ID: 11079664
[TBL] [Abstract][Full Text] [Related]
69. Comparison of four methods for calculating diffusing capacity by the single breath method.
Beck KC; Offord KP; Scanlon PD
Chest; 1994 Feb; 105(2):594-600. PubMed ID: 8306770
[TBL] [Abstract][Full Text] [Related]
70. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
[TBL] [Abstract][Full Text] [Related]
71. The effects of enalapril and losartan on mechanical ventilation-induced sympathoadrenal activation and oxidative stress in rats.
Toklu HZ; Kwon OS; Sakarya Y; Powers SK; Llinas K; Kirichenko N; Sollanek KJ; Wiggs MP; Smuder AJ; Talbert EE; Scarpace PJ; Tümer N
J Surg Res; 2014 May; 188(2):510-6. PubMed ID: 24630519
[TBL] [Abstract][Full Text] [Related]
72. Angiotensin receptor antagonist improves cardiac reflex control of renal sodium handling in heart failure.
DiBona GF; Jones SY; Sawin LL
Am J Physiol; 1998 Feb; 274(2):H636-41. PubMed ID: 9486268
[TBL] [Abstract][Full Text] [Related]
73. High-altitude exposure of three weeks duration increases lung diffusing capacity in humans.
Agostoni P; Swenson ER; Bussotti M; Revera M; Meriggi P; Faini A; Lombardi C; Bilo G; Giuliano A; Bonacina D; Modesti PA; Mancia G; Parati G;
J Appl Physiol (1985); 2011 Jun; 110(6):1564-71. PubMed ID: 21436463
[TBL] [Abstract][Full Text] [Related]
74. Lung membrane diffusing capacity, heart failure, and heart transplantation.
Mettauer B; Lampert E; Charloux A; Zhao QM; Epailly E; Oswald M; Frans A; Piquard F; Lonsdorfer J
Am J Cardiol; 1999 Jan; 83(1):62-7. PubMed ID: 10073787
[TBL] [Abstract][Full Text] [Related]
75. Evaluation of enalapril+losartan treatment with cardiopulmonary exercise test in patients with left ventricular dysfunction.
Akbulut T; Akgöz H; Dayi SU; Celik SE; Gürkan U; Tayyareci G
Angiology; 2006; 57(2):181-6. PubMed ID: 16518525
[TBL] [Abstract][Full Text] [Related]
76. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Goodfield NE; Newby DE; Ludlam CA; Flapan AD
Circulation; 1999 Jun; 99(23):2983-5. PubMed ID: 10368114
[TBL] [Abstract][Full Text] [Related]
77. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
Guazzi M; Agostoni P; Matturri M; Pontone G; Guazzi MD
Am Heart J; 1999 Sep; 138(3 Pt 1):460-7. PubMed ID: 10467196
[TBL] [Abstract][Full Text] [Related]
78. Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.
Xiu JC; Wu P; Xu JP; Guo Z; Lai W; Zhang Y; Li S; Li J; Liu Y
J Endocrinol Invest; 2002 May; 25(5):463-8. PubMed ID: 12035945
[TBL] [Abstract][Full Text] [Related]
79. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P
Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374
[TBL] [Abstract][Full Text] [Related]
80. Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function.
Trevelyan J; Needham EW; Morris A; Mattu RK
Heart; 2005 Aug; 91(8):1053-7. PubMed ID: 16020596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
